The U.S. biotech is holding an analyst and investor meeting focused on the commercial potential of its multiple sclerosis drug Campath. The goal: to convince Paris-based Sanofi-Aventis to raise its hostile takeover offer in a b…
Shares of drugmaker InterMune have more than doubled in premarket trading after a European advisory panel backed the company’s experimental lung treatment Esbriet (pirfenidone), something the biotech failed to accomplish in the…
Shares of drugmaker InterMune have more than doubled in premarket trading after a European advisory panel backed the company’s experimental lung treatment Esbriet (pirfenidone), something the biotech failed to accomplish in the…
Shares of Novartis soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon for $12.9 billion.
Continue reading Novartis Obtains Final Shares of Alcon fo…
According to the latest leaked U.S. diplomatic cables from WikiLeaks, Pfizer hired investigators to try to uncover evidence of corruption in order to pressure the Nigerian attorney general to drop the case against it.
…